- Current report filing (8-K)
March 04 2010 - 9:44AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM 8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported):
February 17,
2009
AXM
PHARMA, INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
|
001-31886
|
|
20-0745214
|
(State
or other jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
of
incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
|
|
|
|
|
20955 Pathfinder Road, Suite 100
Diamond Bar, CA 91765
|
|
10011
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
|
|
|
|
Registrant’s
telephone number, including area code:
(646)
393-4365
|
|
|
|
|
|
|
|
N/A
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General Instruction
A.2. below):
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers
|
(b) Resignation
of Director
On
February 17, 2010, AXM Pharma, Inc. (the “Company”) received the resignation of
Ms. Tracey O’
Neill from her
position as a member of the Company’s Board of Directors. Ms. O’Neill
did not note any disagreement with the Company concerning any matter
relating to the Company's operations, policies or practices as a reason for her
resignation.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
AXM
PHARMA, INC.
|
|
|
|
|
|
|
|
|
|
Dated: February
26, 2010
|
By:
|
/s/ Wei-Shi
Wang
|
|
|
|
Wei-Shi
Wang
|
|
|
|
Chief
Executive Officer
|
|
AXM Pharma (CE) (USOTC:AXMP)
Historical Stock Chart
From Sep 2024 to Oct 2024
AXM Pharma (CE) (USOTC:AXMP)
Historical Stock Chart
From Oct 2023 to Oct 2024